BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28416756)

  • 1. Prognostic significance of ZEB1 and ZEB2 in digestive cancers: a cohort-based analysis and secondary analysis.
    Chen H; Lu W; Huang C; Ding K; Xia D; Wu Y; Cai M
    Oncotarget; 2017 May; 8(19):31435-31448. PubMed ID: 28416756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma.
    Lin S; Chen Q; Tan C; Su M; Min L; Ling L; Zhou J; Zhu T
    BMC Med Genomics; 2024 Jun; 17(1):153. PubMed ID: 38840097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma.
    Chen P; Liu H; Hou A; Sun X; Li B; Niu J; Hu L
    Med Sci Monit; 2018 Feb; 24():1145-1151. PubMed ID: 29476046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks.
    Soleymani L; Zarrabi A; Hashemi F; Hashemi F; Zabolian A; Banihashemi SM; Moghadam SS; Hushmandi K; Samarghandian S; Ashrafizadeh M; Khan H
    Curr Cancer Drug Targets; 2021; 21(9):749-767. PubMed ID: 34077345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran.
    Nourmohammadi B; Tafsiri E; Rahimi A; Nourmohammadi Z; Daneshvar Kakhaki A; Cho W; Karimipoor M
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1633-1639. PubMed ID: 31244281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between the EMT transcription factors ZEB1 and ZEB2 regulates hematopoietic stem and progenitor cell differentiation and hematopoietic lineage fidelity.
    Wang J; Farkas C; Benyoucef A; Carmichael C; Haigh K; Wong N; Huylebroeck D; Stemmler MP; Brabletz S; Brabletz T; Nefzger CM; Goossens S; Berx G; Polo JM; Haigh JJ
    PLoS Biol; 2021 Sep; 19(9):e3001394. PubMed ID: 34550965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of and correlation between BCL6 and ZEB family members in patients with breast cancer.
    Ang L; Zheng L; Wang J; Huang J; Hu HG; Zou Q; Zhao Y; Liu QM; Zhao M; Wu ZS
    Exp Ther Med; 2017 Nov; 14(5):3985-3992. PubMed ID: 29104620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer.
    Zhou X; Men X; Zhao R; Han J; Fan Z; Wang Y; Lv Y; Zuo J; Zhao L; Sang M; Liu XD; Shan B
    Cancer Gene Ther; 2018 May; 25(3-4):68-76. PubMed ID: 29302045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ZEB1 and ZEB2 gene editing mediated by CRISPR/Cas9 in A549 cell line.
    Mohammadinejad R; Sassan H; Pardakhty A; Hashemabadi M; Ashrafizadeh M; Dehshahri A; Mandegary A
    Bratisl Lek Listy; 2020; 121(1):31-36. PubMed ID: 31950837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA XIST promotes the epithelial to mesenchymal transition of retinoblastoma via sponging miR-101.
    Cheng Y; Chang Q; Zheng B; Xu J; Li H; Wang R
    Eur J Pharmacol; 2019 Jan; 843():210-216. PubMed ID: 30472203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-suppressive roles of ΔNp63β-miR-205 axis in epithelial-mesenchymal transition of oral squamous cell carcinoma via targeting ZEB1 and ZEB2.
    Hashiguchi Y; Kawano S; Goto Y; Yasuda K; Kaneko N; Sakamoto T; Matsubara R; Jinno T; Maruse Y; Tanaka H; Morioka M; Hattori T; Tanaka S; Kiyoshima T; Nakamura S
    J Cell Physiol; 2018 Oct; 233(10):6565-6577. PubMed ID: 29150940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src promotes EGF-induced epithelial-to-mesenchymal transition and migration in gastric cancer cells by upregulating ZEB1 and ZEB2 through AKT.
    Zhao L; Li X; Song N; Li A; Hou K; Qu X; Che X; Liu Y
    Cell Biol Int; 2018 Mar; 42(3):294-302. PubMed ID: 29052277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Value of Long Noncoding RNA HOTAIR as a Novel Biomarker in Digestive Cancers: A Meta-Analysis.
    Zhang Y; Zhou Y; Xu T; Tian W; Yang C; Wang X; Zhong S; Ran Q; Yang H; Zhu S
    Technol Cancer Res Treat; 2018 Jan; 17():1533034618756783. PubMed ID: 29444619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumoral and stromal expression of Slug, ZEB1, and ZEB2 in brain metastasis.
    Nagaishi M; Nakata S; Ono Y; Hirata K; Tanaka Y; Suzuki K; Yokoo H; Hyodo A
    J Clin Neurosci; 2017 Dec; 46():124-128. PubMed ID: 28890036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZEB1, ZEB2, and the miR-200 family form a counterregulatory network to regulate CD8
    Guan T; Dominguez CX; Amezquita RA; Laidlaw BJ; Cheng J; Henao-Mejia J; Williams A; Flavell RA; Lu J; Kaech SM
    J Exp Med; 2018 Apr; 215(4):1153-1168. PubMed ID: 29449309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
    Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression.
    Sun S; Yang X; Qin X; Zhao Y
    Protoplasma; 2020 May; 257(3):921-930. PubMed ID: 31933004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis.
    Wu J; Hu L; Wu F; Zou L; He T
    Oncotarget; 2017 May; 8(19):32332-32344. PubMed ID: 28415659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ZEB1-regulated inflammatory phenotype in breast cancer cells.
    Katsura A; Tamura Y; Hokari S; Harada M; Morikawa M; Sakurai T; Takahashi K; Mizutani A; Nishida J; Yokoyama Y; Morishita Y; Murakami T; Ehata S; Miyazono K; Koinuma D
    Mol Oncol; 2017 Sep; 11(9):1241-1262. PubMed ID: 28618162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mesodermal and myogenic specification of hESCs depend on ZEB1 and are inhibited by ZEB2.
    Ninfali C; Siles L; Esteve-Codina A; Postigo A
    Cell Rep; 2023 Oct; 42(10):113222. PubMed ID: 37819755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.